N/A (healthy adults or adults with obese tendencies)
Conditions
Interventions
Oral ingestion of the test products containing eucommia ulmoides oliver leaf extract (6 grains per a day
12 weeks)
Oral ingestion of the controlproducts not containing eucommia ulmoides oliver leaf extract (6 grains per a day
Sponsors
TES Holdings Co., Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: [1]Japanese males and females aged 40-65 years [2]Individuals who are healthy and are not received treatment of disease [3]Individuals whose BMI is over 25-30 [4]Individuals whose written informed consent has been obtained [5]Individuals judged appropriate for the study by the principal
Exclusion criteria
Exclusion criteria: [1]Individuals using medical products [2]Individuals who have a history of serious hepatopathy, kidney damage, heart disease and hematological disease [3]Individuals who are sensitive to test product or other foods, and medical products [4]Individuals who have a history of hepatitis [5]Individuals with serious anemia [6]Individuals whose weight has changed significantly in the past one year [7]Individuals whose amount of exercise has changed significantly in the past one year [8]Individuals whose average number of cigarettes for smoking is over 21/day [9]Individuals who excessively take alcohol (expressed in an amount of alcohol: over 60mg/day) [10]Individuals whose life style will change during the test period by [11]Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplyments in the past 3 month or will ingest those foods during the test period [12]Individuals who participated in other clinical studies in the past three months [13]Individuals who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months [14]Individuals who are or are posslibly, or are lactating [15]Individuals judged inappropriate for the study by the principal
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| [1]CT scanning (visceral fat) [2]Weight, body fat percentage, BMI | — |
Secondary
| Measure | Time frame |
|---|---|
| [1]Blood pressure, pulsation [2]Abdominal girth, hip girth [3]Hematologic test [4]Blood biochemical test [5]Urine analysis [6]Questionnaire survey [7]Subject's diary [8]Doctor's questions | — |
Countries
Japan
Contacts
Public ContactToshiyasu Tamura
TES Holdings Co., Ltd Department of Clinical Trial
Outcome results
None listed